NasdaqGM:CRSPBiotechs
Assessing CRISPR Therapeutics (CRSP) Valuation After Recent Share Price Moves And DCF Upside Indications
CRISPR Therapeutics: Recent Moves and Performance Snapshot
CRISPR Therapeutics (CRSP) has been drawing attention after recent share price moves. The stock closed at US$48.74 and showed mixed returns over the past week, month, and past three months.
See our latest analysis for CRISPR Therapeutics.
The recent 6.23% 1 day share price gain to US$48.74 comes after a softer patch, with a 30 day share price return of 15.95% and a year to date share price return of 9.35%. The 1 year total shareholder...